Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Display session

119P - Insight into early response of sacral chordomas (SC) to high-dose proton therapy (HDPT): First results of CHIPT study

Date

15 Mar 2024

Session

Poster Display session

Presenters

Vesna Miladinovic

Citation

Annals of Oncology (2024) 9 (suppl_2): 1-32. 10.1016/esmoop/esmoop102441

Authors

V. Miladinovic1, A. Krol2, A. Navas3, J. Bloem3

Author affiliations

  • 1 Radiation Oncology Department, LUMC-Leiden University Medical Center, 2333 ZA - Leiden/NL
  • 2 Radiation Oncology, HollandPTC, 2629 JH - Delft/NL
  • 3 Department Of Radiology, LUMC-Leiden University Medical Center, 2333 ZA - Leiden/NL

Resources

This content is available to ESMO members and event participants.

Abstract 119P

Background

Currently used Response Evaluation Criteria in Solid Tumors (RECIST) based on lesion diameter is insufficient for proper assessment of SC response to HDPT as despite relatively small volume changes durable HDPT response is observed. Functional magnetic resonance imaging (MRI) parameters showed good potential in better portraying these changes. The aim of this prospective study is to evaluate early changes of functional MRI parameters in SC occurring during and following HDPT.

Methods

Inclusion criteria: histological diagnosis of SC, lesion size ≥ 1cm, no MRI contraindication, WHO performance score < 3, and referral to HollandPTC (Delft, Netherlands) for definitive 74GyE PT or combined PT (50GyE+resection+24GyE). Inclusion period: August 2020 - October 2023. The study was approved by the medical ethical committee. All patients signed the consent form. In each patient 3.0T MRI was made at the inclusion, mid-treatment (week 4), end of the treatment (week 8), and 6 months and 1 year following the first fraction. Functional MRI parameters were measured within 4 circular regions - each at a different scan slice. Differences in parameter values at different timepoints were analyzed with Mann-Whitney-U (α=0.05).

Results

Ten conventional SC patients (5 M; median age 70, range 39-78) were included; 8 received definitive HDPT only and 2 the combined treatment. Noticeable changes of parameters occurred at week 8 where ADC mean increased by 15.0% and Ktrans, Ve, and Vp decreased by 59.4%, 90.0% and 68.2%, respectively, compared to the inclusion (Table) One year later all functional parameters except ADC mean decreased.

Table: 119P

Mean values of MRI parameters at different timepoints

Inclusion week 4 week 8 6 months 1 year
ADCmean [10−3mm2/s] 1.523 1.548 1.752 1.668 1.525
Ktrans [10−3/min] 60.68 78.61 24.61 43.09 49.86
Ve [10−3] 689.58 212.06 69.20 199.61 0.00
Vp [10−3] 3.336 2.331 1.060 1.457 0.160

Conclusions

Functional MRI parameters give a good insight into the response of SC to HDPT - already at week 8 of HDPT. The observed decrease of Ktrans, Ve, and Vp values most likely corresponds to necrosis; yet for a better understanding of microscopic processes portrayed by these parameters, they should be correlated with histopathology.

Clinical trial identification

NCT04832620.

Editorial acknowledgement

Legal entity responsible for the study

Leiden University Medical Center, Leiden, The Netherlands; HollandPTC, Delft, The Netherlands.

Funding

Varian, Siemens Healthineers Company, HollandPTC, Delft, The Netherlands (grant number 2018010).

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.